Orpea's smaller PE-backed French rivals who are spilling out across Europe say they are not worried by the Orpea scandal. Colissee has just acquired in Portugal for the first time. HBI talks to the C-level at the French operator to learn more.
After a strong performance in 2021, international lab group Eurofins plans to build diagnostic lab hubs, which will enable it to increase the volume of tested samples. HBI talks with the source close to the company to find out more.
Germany, France and Italy are Europe's largest for-profit laboratory services markets, with heavyweight groups like Sonic, Synlab, and Cerba having significant market shares. As the major players continue to make large and bolt-on acquisitions, just how consolidated are these markets.
A five and a half year education (Batchelor + Masters) as a doctor for just €100,000? That is what is on offer from EDU Malta, a for-profit educational institute with statutes which commit it to working for the public good. It is working closely with Fresenius Helios and other German hospitals and is looking for hospital partners in other countries. So how does it work, what are EDU’s plans and what role could this play in dealing with the massive world shortage of doctors?
Quironsalud, the Spanish arm of Fresenus Helios has expanded its Colombian business with the acquisition of Centro Oncológico de Antioquia and ophthalmology centre Clínica Clofán. In its nine month results Fresenius stated that Latin America were strong and "notably above expectations." We look at a booming market where Fresenius Helios spent the lion's share of its €770m on M&A deals in 2020 and 2019 alone.
Australia's largest oncology provider Icon Group has been bought by EQT's infrastructure arm for AUS$2.4bn. Its CEO Mark Middleton tells HBI that the group now has its sights set on Europe.
Since we last interviewed health-tech provider Dr Nadine Hachach-Haram, the Proximie CEO, last year, the group's technology has been deployed in 200 additional hospitals globally, and it has plans to scale its services up following its recent partnership with telehealth rival, Teladoc Health. HBI speaks to Hachach-Haram to find out more.
Running international hospitals in diverse cultures brings challenges and opportunities, an expert panel at HBI 2021 said and reviewed shared management learnings.
Some revered global brands have become unstuck in their internationalisation by ceding control of a brand without any quality assurance. Panellists at HBI 2021 discussed how to manage that process more effectively.
Is healthcare in the Middle East and North Africa (MENA) the next big investment opportunity? According to a panel at HBI 2021 on the MENA region the answer is an emphatic yes, and the region is 'open for business - though not a market for the faint of heart.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.